Leydig-cell tumour in children: Variable clinical presentation, diagnostic features, follow-up and genetic analysis of four cases

Hormone Research

Volumn 67, Issue 2, 2007, Pages 89-95

  Petkovic, Vibor ^a   Salemi, Souzan ^a   Vassella, Erik ^b   Karamitopoulou Diamantis, Evanthia ^b   Meinhardt, Udo J ^a   Flück, Christa E ^a   Mullis, Primus E ^a,c  

^a PSI   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c UNIVERSITY OF BERN   (Switzerland)

Author keywords

Adrenarche; Cyclin dependent kinase 4 gene; G protein genes; Gialpha (gip2) subunits; Gsalpha (gsp); Leydig cell tumour; Luteinizing hormone receptor; Precocious puberty

Indexed keywords

ARTICLE; CASE REPORT; CHILD; CLINICAL FEATURE; CYCLIN DEPENDENT KINASE GENE 4; FOLLOW UP; G PROTEIN ALPHA SUBUNIT GENE; GENE; GENE MUTATION; GENETIC ANALYSIS; HUMAN; LEYDIG CELL TUMOR; LUTEINIZING HORMONE RECEPTOR GENE; MALE; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL;

ANDROGENS; CHILD; CHILD, PRESCHOOL; HUMANS; LEYDIG CELL TUMOR; MALE; TESTICULAR NEOPLASMS; TESTIS;

EID: 33847417530     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000096356     Document Type: Article

References (24)

1. Ise T, Ohtsuki H, Matsumoto K, Sano R: Management of malignant testicular tumors in children. Cancer 1976;37:1539-1545.
2. Ciftci AO, Bingol-Kologlu M, Senocak ME, Tanyel FC, Buyukpamukcu M, Buyukpamukcu N: Testicular tumors in children. J Pediatr Surg 2001;36:1796-1801.
3. Merlini E, Seymandi PL, Betta PG, Bussi G: Testis sparing enucleation of a Leydig-cell tumour in a boy. Pediatr Med Chir 2003;25:63-65.
4. Liu G, Duranteau L, Carel JC, Monroe J, Doyle DA, Shenker A: Leydig-cell tumors caused by an activating mutation of the gene encoding the luteinizing hormone receptor. N Engl J Med 1999;341:1731-1736.
5. Themmen APN, Huhtaniemi IT: Mutations of gonadotropins and gonadotropin receptors: elucidating the physiology and pathophysiology of pituitary-gonadal function. Endocr Rev 2000;21:551-583.
6. Canto P, Soderlund D, Ramon G, Nishimura E, Mendez JP: Mutational analysis of the luteinizing hormone receptor gene in two individuals with Leydig cell tumors. Am J Med Genet 2002;108:148-152.
7. Richter-Unruh A, Martens JW, Verhoef-Post M, Wessels HT, Kors WA, Sinnecker GH, Boehmer A, Drop SL, Toledo SP, Brunner HG, Themmen AP: Leydig cell hypoplasia: cases with new mutations, new polymorphisms and cases without mutations in the luteinizing hormone receptor gene. Clin Endocrinol (Oxf) 2002;56:103-112.
8. Kremer H, Martens JW, van Reen M, Verhoef-Post M, Wit JM, Otten BJ, Drop SL, Delemarre-van de Waal HA, Pombo-Arias M, De Luca F, Potau N, Buckler JM, Jansen M, Parks JS, Latif HA, Moll GW, Epping W, Saggese G, Mariman EC, Themmen AP, Brunner HG: A limited repertoire of mutations of the luteinizing hormone (LH) receptor gene in familial and sporadic patients with male LH-independent precocious puberty. J Clin Endocrinol Metab 1999;84:1136-1140.
9. Fragoso MC, Latronico AC, Carvalho FM, Zerbini MC, Marcondes JA, Araujo LM, Lando VS, Frazzatto ET, Mendonca BB, Villares SM: Activating mutation of the stimulatory G protein (gsp) as a putative cause of ovarian and testicular human stromal Leydig cell tumors. J Clin Endocrinol Metab 1998;83:2074-2078.
10. Vax VV, Bibi R, Diaz-Cano S, Gueorguiev M, Kola B, Borboli N, Bressac-de Paillerets B, Walker GJ, Dedov II, Grossman AB, Korbonits M: Activating point mutations in cyclin-dependent kinase 4 are not seen in sporadic pituitary adenomas, insulinomas or Leydig cell tumours. J Endocrinol 2003;178:301-310.
11. Rane SG, Cosenza SC, Mettus RV, Reddy EP: Germ line transmission of the Cdk4 (R24C) mutation facilitates tumorigenesis and escape from cellular senescence. Mol Cell Biol 2002;22:644-656.
12. Brook CGD: A Guide to the Practice of Paediatric Endocrinology. Chapter 3. Puberty. Cambridge University Press, 1993.
13. Blair JC, Savage MO: Normal and abnormal puberty; in Besser GM, Thorner MO (eds): Comprehensive Clinical Endocrinology. Edinburgh Scotland, Elsevier Science, 2002, vol 3, pp 319-337.
14. Gittes RF, Smith G, Conn CA, Smith F: Local androgenic effect of interstitial cell tumor of the testis. J Urol 1970;104:774-777.
15. Canto P, Soderlund D, Reyes E, Mendez JP: Mutations in the desert hedgehog (DHH) gene in patients with 46,XY complete pure gonadal dysgenesis. J Clin Endocrinol Metab 2004;89:4480-4483.
16. Candeliere GA, Roughley PJ, Glorieux FH: Polymerase chain reaction-based technique for the selective enrichment and analysis of mosaic arg201 mutations in G s alpha from patients with fibrous dysplasia of bone. Bone 1997;21:201-206.
17. Lyons J, Landis CA, Harsh G, Vallar L, Grunewald K, Feichtinger H, Duh QY, Clark OH, Kawasaki E, Bourne HR: Two G protein oncogenes in human endocrine tumors. Science 1990;249:655-659.
18. Jorge BH, Agarwal SK, Lando VS, Salvatori R, Barbero RR, Abelin N, Levine MA, Marx SJ, Toledo SP: Study of the multiple endocrine neoplasia type 1, growth hormone-releasing hormone receptor, Gs alpha, and Gi2 alpha genes in isolated familial acromegaly. J Clin Endocrinol Metab 2001;86:542-544.
19. Shen Y, Mamers P, Jobling T, Burger HG, Fuller PJ: Absence of the previously reported G protein oncogene (gip2) in ovarian granulosa cell tumors. J Clin Endocrinol Metab 1996;81:4159-4161.
20. Prader A, Largo RH, Molinari L, Issler C: Physical growth of Swiss children from birth to 20 years of age. Helv Paediatr Acta 1989;52(suppl):1-125.
21. Greulich WW, Pyle SI: Radiographic Atlas of Skeletal Development of the Hand and Wrist. Stanford California, Stanford University Press, 1959.
22. Marshall WA, Tanner JM: Variations in pattern of pubertal changes in boys. Arch Dis Child 1970;45:15-23.
23. Konrad D, Schoenle EJ: Ten-year follow-up in a boy with Leydig cell tumor after selective surgery. Horm Res 1999;51:96-100.
24. Leschek EW, Chan WY, Diamond DA, Kaefer M, Jones J, Barnes KM, Cutler GB Jr: Nodular Leydig cell hyperplasia in a boy with familial male-limited precocious puberty. J Pediatr 2001;138:949-951.